Hippocampus-Sparing Radiation a New Option in Brain Mets Patients Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
Aggressive RT, Surgery Doubles OS in NSCLC With Limited Mets If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
SBRT Doubles 5-Year Survival in Oligometastatic Cancers Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
Lung Screening Saves Lives, but Who Should Be Screened? Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
Lung Cancer Screening Rates Fall Short in VA Adherence was 77% among those with negative baseline screens Oct 04, 2018
More Evidence that Screening Cuts Lung Cancer Deaths Significantly lower risk in men and women Sep 26, 2018
Newer ALK Inhibitor Tops Standard in NSCLC Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
Anti-PD-L1 Drug Boosts Survival in Stage III NSCLC New standard of care for patients with inoperable disease Sep 26, 2018
Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancer Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018
No Survival Benefit with Cranial RT for NSCLC Better disease-free survival, fewer brain mets Sep 25, 2018
Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin Two trials show no survival benefit and more toxicity Jul 26, 2018
Surveillance Not Resection Called Best For Subsolid Lung Nodules Opacities tied to increase in lung cancers, but never fatal during a decade of follow-up Jul 25, 2018
Keytruda Alone Bests Chemo in Advanced NSCLC Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
Refusing Lung Cancer Treatment: Class Trumps Race Wide variation in groups at highest risk of turning down treatment May 25, 2018
Lung Cancer Screening Rates Disappoint Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
'Unsolved Mysteries' on Display at AACR Large, diverse program reflects rapid pace of advancement Apr 13, 2018
ACS: E-Cigarettes OK for Smoking Cessation ... with Caveats Short period of dual use OK, if goal is to quit Feb 22, 2018
Weather Not a Factor in Pneumothorax Risk with Lung Biopsy No relationship seen between complications and atmospheric conditions Nov 27, 2017
Shared Decision-Making Strategies for Lung Ca Screening Get High Marks Patient satisfaction high with physician-led and web-based approaches Nov 02, 2017
Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
Dacomitinib Sets PFS Record in Phase III NSCLC Trial Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
Advanced Ca Patients Benefit from Online Symptom Reports Patient-reported outcomes tied to increased survival Jun 05, 2017
Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
Asthma Biologic, Rally Among ATS Highlights Attendees to organize on Capitol Hill; will also hear benralizumab phase III results May 17, 2017
ESTRO: Tumor-Adapted RT Lowers Pneumonitis in Lung Cancer Selected presentations from the European RT meeting May 07, 2017
MSK Cancer Alliance: Mainly About Medicine Bi-directional relationship strengthens regional cancer care Mar 11, 2017
Fewer 'Nails in the Coffin' as Smoking Rate Declines But "smoke-free" remains aspiration, not fact Nov 11, 2016
Novel App Seems to Extend Lung Cancer Survival Web app offers early detection of relapse, complications between healthcare visits Jun 07, 2016
Novel Agent Offers Hope in Small Cell Lung Cancer Antibody-drug conjugate Rova-T looks good, but in very early trial Jun 05, 2016
Palliative Care Benefits Caregivers, Too Better QoL, less depression among 'downstream' effects May 20, 2016
Slippery Slope: A Targeted Therapy That Misses the Mark? Afinitor racks up FDA approvals, but where is the evidence? Dec 13, 2015
Post-Op CT Scans May Improve Lung Cancer Survival 4-year survival rate up 12 percentage points in patients having scans Sep 28, 2015
